2-[2-chloro-5-[(2-thienylsulfonamido)methyl]phenylamino]-N-cyclohexylmethyl-1-methylbenzimidazole-5-carboxamide | 1242268-70-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-[2-chloro-5-[(2-thienylsulfonamido)methyl]phenylamino]-N-cyclohexylmethyl-1-methylbenzimidazole-5-carboxamide
• 英文别名: (2-Chloro-5-[(2-thienylsulfonamido)methyl]phenylamino}-N-cyclohexylmethyl-1-methylbenzimidazole-5-carboxamide；2-[2-chloro-5-[(thiophen-2-ylsulfonylamino)methyl]anilino]-N-(cyclohexylmethyl)-1-methylbenzimidazole-5-carboxamide
• CAS: 1242268-70-7
• 化学式: C₂₇H₃₀ClN₅O₃S₂
• 分子量: 572.152
• InChiKey: YWMQZNMQFUQZFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  38
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  142
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-噻吩磺酰氯 、 2-(5-aminomethyl-2-chlorophenylamino)-N-cyclohexylmethyl-1-methylbenzimidazole-5-carboxamide 在 三乙胺 作用下， 以 乙腈 为溶剂， 反应 12.0h， 以18%的产率得到2-[2-chloro-5-[(2-thienylsulfonamido)methyl]phenylamino]-N-cyclohexylmethyl-1-methylbenzimidazole-5-carboxamide
  参考文献：
  名称：

  [EN] 3H-IMIDAZO [4, 5 -C] PYRIDINE- 6 -CARBOXAMIDES AS ANTI- INFLAMMATORY AGENTS
  [FR] 3H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXAMIDES EN TANT QU'ANTI-INFLAMMATOIRES

  摘要：

  本发明涉及通式(I)中的化合物，其中A、L、M、Q2、Q3、Q4、R1、R5、Ra、Rb、Rc、W、X、Y、Z1、Z2、Z3在描述中有定义，及其盐，特别是其生理上可接受的盐。这些化合物可能在治疗和/或预防炎症性疾病及相关症状方面具有潜在的用途，特别是在治疗和/或预防疼痛方面。本发明还涉及将这些化合物用作药物、含有它们的药物组合物以及它们的制备。

  公开号：

  WO2010100249A1

文献信息

• NEW COMPOUNDS
  申请人：PFAU Roland

  公开号：US20120196897A1

  公开（公告）日：2012-08-02

  The present invention relates to compounds of general formula I in which A, L, M, Q 2 , Q 3 , Q 4 , R 1 , R 5 , R a , R b , R c , W, X, Y, Z 1 , Z 2 , Z 3 are defined in the description, the salts thereof, particularly the physiologically acceptable salts thereof. The compounds are of potential utility in the treatment and/or prevention of inflammatory diseases and associated conditions, in particular, in the treatment and/or prevention of pain. The invention also relates to the use of such compounds as medicaments, to pharmaceutical compositions containing them, and to their preparation.

  本发明涉及一般式I的化合物，其中A，L，M，Q2，Q3，Q4，R1，R5，Ra，Rb，Rc，W，X，Y，Z1，Z2，Z3在描述中定义，其盐，特别是其生理上可接受的盐。这些化合物在治疗和/或预防炎症性疾病和相关病症方面具有潜在的用途，特别是在治疗和/或预防疼痛方面。本发明还涉及将这些化合物用作药物、包含它们的制药组合物以及它们的制备。
• Compounds
  申请人：Pfau Roland

  公开号：US08921405B2

  公开（公告）日：2014-12-30

  The present invention relates to compounds of general formula I in which A, L, M, Q2, Q3, Q4, R1, R5, Ra, Rb, Rc, W, X, Y, Z1, Z2, Z3 are defined in the description, the salts thereof, particularly the physiologically acceptable salts thereof. The compounds are of potential utility in the treatment and/or prevention of inflammatory diseases and associated conditions, in particular, in the treatment and/or prevention of pain. The invention also relates to the use of such compounds as medicaments, to pharmaceutical compositions containing them, and to their preparation.

  本发明涉及化合物I的一般式，其中A，L，M，Q2，Q3，Q4，R1，R5，Ra，Rb，Rc，W，X，Y，Z1，Z2，Z3在说明书中有定义，其盐，特别是生理上可接受的盐。该化合物在治疗和/或预防炎症性疾病和相关病症方面具有潜在效用，特别是在治疗和/或预防疼痛方面。本发明还涉及将这些化合物用作药物、含有它们的药物组合物以及它们的制备。
• 2-AMINOBENZIMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2403852B1

  公开（公告）日：2014-10-29
• METHODS OF TREATING DISEASES CHARACTERISED BY VASOCONSTRICTION
  申请人：GESYNTA PHARMA AB

  公开号：US20190038603A1

  公开（公告）日：2019-02-07

  There is herein provided a compound that is an mPGES-1 inhibitor, or a prodrug thereof, for use in the treatment or prophylaxis of a disease or disorder characterised by vasoconstriction.
• US8921405B2
  申请人：——

  公开号：US8921405B2

  公开（公告）日：2014-12-30